酶替代疗法与佩病治疗的最佳支持性护理相比:系统性审查和网络元分析
Mark Corbett1, Chinyereugo Umemneku-Chikere1, Sarah Nevitt1
1Centre for Reviews and Dissemination, University of York, York, UK.
Health technology assessment (Winchester, England)
|February 16, 2026
概括
酶替代疗法为晚发佩病患者提供了适度的短期益处,改善了行走能力. 长期有效性和治疗方法之间的比较仍然不确定,随着时间的推移观察到逐渐下降.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚发佩病 (LOPD) 是一种罕见的遗传疾病,导致肌肉逐渐疲软和呼吸衰竭.
- 酶替代疗法 (ERT) 是LOPD的标准治疗方法.
- 呼吸衰竭是LOPD患者死亡的主要原因.
研究的目的:
- 评估ERT在管理LOPD方面的临床影响.
- 为了比较ERT与最佳支持性护理 (BSC) 的有效性.
主要方法:
- 随机对照试验 (RCT) 和前性研究的系统审查和网络元分析.
- 在LOPD中搜索到2024年5月进行的ERT和BSC证据.
- 网络元分析估计了6分钟步行测试 (6MWT) 和强迫生命能力 (FVC) 的治疗效果.
主要成果:
- 在未接受ERT的患者中,ERT在约1年后显示了适度的6MWT改善 (~25-54m) 与安慰剂相比.
- 在ERT和安慰剂之间没有发现预测的FVC%的显著差异.
- 长期研究表明,最初的ERT收益维持了1-3年,随后逐渐下降至15年.
结论:
- 在没有ERT的LOPD患者中,ERT在6MWT中提供了中度的短期改善.
- 有限证据表明,特定ERT (alglucosidase alfa, avalglucosidase alfa, cipaglucosidase alfa) 之间的显著结果差异存在.
- 长期的比较有效性和ERT对疾病进展和支持性护理需求的影响需要进一步研究.
相关概念视频
Continuous Renal Replacement Therapy
1.2K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.2K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
643
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
643
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
237
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
237
Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Chronic Pancreatitis II: Collaborative Care
388
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
388


